Enzolytics Stock Gross Profit

ENZC Stock  USD 0.0009  0.0001  10.00%   
Enzolytics fundamentals help investors to digest information that contributes to Enzolytics' financial success or failures. It also enables traders to predict the movement of Enzolytics Pink Sheet. The fundamental analysis module provides a way to measure Enzolytics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Enzolytics pink sheet.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Enzolytics Company Gross Profit Analysis

Enzolytics' Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.

Gross Profit

 = 

Revenue

-

Cost of Revenue

More About Gross Profit | All Equity Analysis

Current Enzolytics Gross Profit

    
  52.81 K  
Most of Enzolytics' fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Enzolytics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Competition

According to the company disclosure, Enzolytics reported 52.81 K of gross profit. This is 100.0% lower than that of the Healthcare sector and 99.99% lower than that of the Biotechnology industry. The gross profit for all United States stocks is 100.0% higher than that of the company.

Enzolytics Gross Profit Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Enzolytics' direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Enzolytics could also be used in its relative valuation, which is a method of valuing Enzolytics by comparing valuation metrics of similar companies.
Enzolytics is currently under evaluation in gross profit category among its peers.

Enzolytics Fundamentals

About Enzolytics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Enzolytics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Enzolytics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Enzolytics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Enzolytics Pink Sheet

Enzolytics financial ratios help investors to determine whether Enzolytics Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Enzolytics with respect to the benefits of owning Enzolytics security.